BAJAJ BROKING

Notification
No new Notification messages
Nisus Finance Services IPO is Open!
Apply for the Nisus Finance Services IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
solara active pha sci ltd stock

SOLARA ACTIVE PHA SCI LTD Share Price

813.65 -14.50 (-1.75%)
Dec 04 2024 03:30 PM Pharmaceuticals NSE: SOLARA

SOLARA ACTIVE PHA SCI LTD Share Price Update

As of the latest trading session, SOLARA ACTIVE PHA SCI LTD share price is currently at 813.65, which is down by -14.50 from its previous closing. Today, the stock has fluctuated between 810.65 and 838.75. Over the past year, SOLARA ACTIVE PHA SCI LTD has achieved a return of 168.90 %. In the last month alone, the return has been 3.90 %. Read More...

SOLARA ACTIVE PHA SCI LTD Performance

Day Range

Low810.65 High838.75
814.00

52 Week Range

Low 291.33 High 882.80
814.00

SOLARA ACTIVE PHA SCI LTD Share Price

3672

541540

SOLARA

img img img img
No Data Available

Open Price

833.80

Prev. Close

828.15

Volume (Shares)

95929.00

Total traded value

780.86

Upper Circuit

869.55

Lower Circuit

786.75

Note: The current prices & values are delayed, Login to your account for live updates.

SOLARA ACTIVE PHA SCI LTD Fundamentals


(Standalone)

Market Cap (Cr) 2928.83
PE Ratio (TTM) -5.58
Book Value / Share 301.38
Beta 1.05
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) 8.02

SOLARA ACTIVE PHA SCI LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 346.95
Operating Expense 339.25
Net Profit 8.02
Net Profit Margin (%) 2.31
Earnings Per Share (EPS) 2.11
EBITDA 61.64
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 363.49
Operating Expense 377.19
Net Profit -12.32
Net Profit Margin (%) -3.38
Earnings Per Share (EPS) -3.20
EBITDA 43.62
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 299.43
Operating Expense 345.35
Net Profit -256.40
Net Profit Margin (%) -85.62
Earnings Per Share (EPS) -71.23
EBITDA -111.89
Effective Tax Rate (%) -52.97
Particulars DEC 2023 (Values in Cr)
Revenue 248.73
Operating Expense 461.73
Net Profit -275.33
Net Profit Margin (%) -110.69
Earnings Per Share (EPS) -76.49
EBITDA -223.99
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 425.24
Operating Expense 438.17
Net Profit -15.26
Net Profit Margin (%) -3.58
Earnings Per Share (EPS) -4.24
EBITDA 35.35
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1288.92
Operating Expense 1592.98
Net Profit -566.87
Net Profit Margin (%) -43.98
Earnings Per Share (EPS) -157.48
EBITDA -279.33
Effective Tax Rate (%) -16.08
Particulars MAR 2023 (Values in Cr)
Revenue 1443.81
Operating Expense 1510.73
Net Profit -22.21
Net Profit Margin (%) -1.53
Earnings Per Share (EPS) -6.17
EBITDA 156.18
Effective Tax Rate (%) 50.40
Particulars MAR 2022 (Values in Cr)
Revenue 1268.34
Operating Expense 1375.27
Net Profit -58.56
Net Profit Margin (%) -4.61
Earnings Per Share (EPS) -16.29
EBITDA 95.62
Effective Tax Rate (%) 36.11
Particulars MAR 2021 (Values in Cr)
Revenue 1616.88
Operating Expense 1424.33
Net Profit 220.96
Net Profit Margin (%) 13.66
Earnings Per Share (EPS) 68.86
EBITDA 413.74
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 1321.75
Operating Expense 1236.77
Net Profit 112.49
Net Profit Margin (%) 8.51
Earnings Per Share (EPS) 43.47
EBITDA 284.04
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 259.42
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.83
EBITDA Margin -7.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 416.73
ROE % -1.47
ROCE % 1.74
Total Debt to Total Equity 0.68
EBITDA Margin 10.83
Particulars MAR 2022 (Values in Cr)
Book Value / Share 423.57
ROE % -3.74
ROCE % -0.65
Total Debt to Total Equity 0.53
EBITDA Margin 7.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 442.12
ROE % 16.55
ROCE % 14.72
Total Debt to Total Equity 0.50
EBITDA Margin 25.64
Particulars MAR 2020 (Values in Cr)
Book Value / Share 368.69
ROE % 11.22
ROCE % 11.13
Total Debt to Total Equity 0.62
EBITDA Margin 21.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 260.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.83
EBITDA Margin -6.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 417.54
ROE % -1.47
ROCE % 1.74
Total Debt to Total Equity 0.68
EBITDA Margin 10.82
Particulars MAR 2022 (Values in Cr)
Book Value / Share 424.18
ROE % -3.75
ROCE % -0.67
Total Debt to Total Equity 0.53
EBITDA Margin 7.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 443.30
ROE % 16.47
ROCE % 14.66
Total Debt to Total Equity 0.50
EBITDA Margin 25.59
Particulars MAR 2020 (Values in Cr)
Book Value / Share 370.50
ROE % 10.96
ROCE % 10.96
Total Debt to Total Equity 0.61
EBITDA Margin 21.49
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.60
Total Assets 2350.96
Total Liabilities 2350.96
Total Equity 936.58
Share Outstanding 35996267
Price to Book Ratio 1.43
Return on Assets (%) -24.13
Return on Capital (%) -29.31
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.89
Total Assets 2899.28
Total Liabilities 2899.28
Total Equity 1502.45
Share Outstanding 35996267
Price to Book Ratio 0.79
Return on Assets (%) -0.76
Return on Capital (%) -0.89
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.25
Total Assets 2944.96
Total Liabilities 2944.96
Total Equity 1527.18
Share Outstanding 35996267
Price to Book Ratio 1.57
Return on Assets (%) -1.97
Return on Capital (%) -2.28
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 198.54
Total Assets 2613.58
Total Liabilities 2613.58
Total Equity 1592.77
Share Outstanding 35929767
Price to Book Ratio 3.15
Return on Assets (%) 8.47
Return on Capital (%) 10.07
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 56.78
Total Assets 2153.50
Total Liabilities 2153.50
Total Equity 1090.23
Share Outstanding 26855267
Price to Book Ratio 1.20
Return on Assets (%) 5.32
Return on Capital (%) 6.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.48
Total Assets 2346.60
Total Liabilities 2346.60
Total Equity 937.42
Share Outstanding 35996267
Price to Book Ratio 1.43
Return on Assets (%) -24.15
Return on Capital (%) -29.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.71
Total Assets 2894.95
Total Liabilities 2894.95
Total Equity 1503.13
Share Outstanding 35996267
Price to Book Ratio 0.79
Return on Assets (%) -0.76
Return on Capital (%) -0.89
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 47.14
Total Assets 2937.44
Total Liabilities 2937.44
Total Equity 1527.05
Share Outstanding 35996267
Price to Book Ratio 1.57
Return on Assets (%) -1.99
Return on Capital (%) -2.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 198.38
Total Assets 2610.17
Total Liabilities 2610.17
Total Equity 1592.79
Share Outstanding 35929767
Price to Book Ratio 3.15
Return on Assets (%) 8.46
Return on Capital (%) 10.05
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 56.58
Total Assets 2151.61
Total Liabilities 2151.61
Total Equity 1090.79
Share Outstanding 26855267
Price to Book Ratio 1.20
Return on Assets (%) 5.22
Return on Capital (%) 6.71
Particulars MAR 2024 (Values in Cr)
Net Income -488.42
Cash from Operations 107.97
Cash from Investing -3.51
Cash from Financing -105.65
Net change in Cash -0.29
Free Cash Flow 149.03
Particulars MAR 2023 (Values in Cr)
Net Income -44.82
Cash from Operations 142.71
Cash from Investing -81.14
Cash from Financing -112.76
Net change in Cash -37.65
Free Cash Flow 254.02
Particulars MAR 2022 (Values in Cr)
Net Income -91.10
Cash from Operations -223.93
Cash from Investing -242.85
Cash from Financing 333.57
Net change in Cash -151.31
Free Cash Flow -15.31
Particulars MAR 2021 (Values in Cr)
Net Income 221.50
Cash from Operations 188.82
Cash from Investing -106.30
Cash from Financing 92.49
Net change in Cash 141.65
Free Cash Flow 363.29
Particulars MAR 2020 (Values in Cr)
Net Income 114.91
Cash from Operations 266.49
Cash from Investing -358.81
Cash from Financing 96.98
Net change in Cash -19.68
Free Cash Flow 535.36
Particulars MAR 2024 (Values in Cr)
Net Income -488.33
Cash from Operations 110.03
Cash from Investing -4.66
Cash from Financing -106.52
Net change in Cash -0.23
Free Cash Flow 153.10
Particulars MAR 2023 (Values in Cr)
Net Income -44.78
Cash from Operations 142.46
Cash from Investing -81.13
Cash from Financing -112.76
Net change in Cash -37.72
Free Cash Flow 253.77
Particulars MAR 2022 (Values in Cr)
Net Income -91.66
Cash from Operations -223.72
Cash from Investing -243.08
Cash from Financing 333.59
Net change in Cash -151.26
Free Cash Flow -14.84
Particulars MAR 2021 (Values in Cr)
Net Income 220.96
Cash from Operations 187.01
Cash from Investing -105.25
Cash from Financing 92.50
Net change in Cash 141.69
Free Cash Flow 360.50
Particulars MAR 2020 (Values in Cr)
Net Income 112.49
Cash from Operations 265.53
Cash from Investing -358.81
Cash from Financing 97.01
Net change in Cash -19.78
Free Cash Flow 534.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 33.57 3.18 447.69 37.54 / 77.70
BLISS GVS PHARMA LTD 163.60 20.48 1.70 1722.74 92.25 / 172.40
CIPLA LTD 1534.40 26.84 4.36 123920.06 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 406.85 141.27 4.12 1197.40 145.00 / 413.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 58.42 50.80 9.93 447.69 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.60 45.60 7.27 2167.14 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6597.95 128.14 24.28 16494.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 163.60 21.30 1.68 1722.74 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 834.00
  • 26 Days 796.00
  • 10 Days 812.80
  • 50 Days 781.50
  • 12 Days 806.80
  • 100 Days 737.90
  • 20 Days 800.30
  • 200 Days 389.30
839.45
PIVOT
First Resistance 853.75
Second Resistance 879.35
Third Resistance 893.65
First Support 813.85
Second Support 799.55
Third Support 773.95
RSI 57.86
MACD 10.79
Commodity Channel Index (CCI) 115.28
ADX 24.50
Williams % R -36.00

Over 1 Month

down

3.90

Over 3 Months

down

12.23

Over 6 Months

down

103.25

Over 1 Year

down

168.90

Over 3 Years

down

-8.30

Over 5 Years

down

15.09

SOLARA ACTIVE PHA SCI LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SOLARA ACTIVE PHA SCI LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
7.1
Promoter Holdings
37.26
FII
14.24
DII
3.37
Promoter Shares(Pledge Percentage)
38.0
Name Category Shares Shares%
Devicam Capital Llp Shareholding of Promoter and Promoter Group 7463560.0 15.55
Spiracca Ventures Llp . Public Shareholding 3738500.0 7.79
Pronomz Ventures Llp Shareholding of Promoter and Promoter Group 2332463.0 4.86
Tpg Growth Iv Sf Pte. Ltd. Public Shareholding 2130321.0 4.44
Authum Investment And Infrastructure Limited Public Shareholding 2047404.0 4.27
Srjr Enterprise Llp Shareholding of Promoter and Promoter Group 1700100.0 3.54
Arunkumar Pillai Shareholding of Promoter and Promoter Group 1668463.0 3.48
The Scottish Oriental Smaller Companies Trustplc Public Shareholding 1358005.0 2.83
K R Ravishankar Shareholding of Promoter and Promoter Group 1325260.0 2.76
Fssa Indian Subcontinent Fund As Sub Fund Of First Sentier Investors Global Umbrella Fund Public Shareholding 1140083.0 2.37
Caisse De Depot Et Placement Du Quebec - First Sentier Investors International Im Public Shareholding 1084950.0 2.26
Hbm Healthcare Investments (cayman) Ltd Public Shareholding 1046610.0 2.18
Chayadeep Ventures Llp Shareholding of Promoter and Promoter Group 1012400.0 2.11
Agnus Capital Llp Shareholding of Promoter and Promoter Group 849635.0 1.77
Route One Offshore Master Fund, L.p. Public Shareholding 696932.0 1.45
Raptakos Brett & Co Limited Public Shareholding 664891.0 1.39
Aditya Birla Sun Life Trustee Private Limited A/c Aditya Birla Sun Life Flexi Cap Fund Public Shareholding 615000.0 1.28
Turnaround Opportunities Fund Public Shareholding 572594.0 1.19
Chayadeep Properties Private Limited Shareholding of Promoter and Promoter Group 525730.0 1.1
Agraganya Private Trust Shareholding of Promoter and Promoter Group 523384.0 1.09
Karuna Business Solutions Llp Shareholding of Promoter and Promoter Group 69526.0 0.14
Deepa Arun Kumar Shareholding of Promoter and Promoter Group 58002.0 0.12
Tarini Arun Kumar Shareholding of Promoter and Promoter Group 53333.0 0.11
Aditya Arun Kumar Shareholding of Promoter and Promoter Group 53333.0 0.11
Sajitha Pillai Shareholding of Promoter and Promoter Group 53333.0 0.11
Padmakumar Karunakaran Pillai Shareholding of Promoter and Promoter Group 55190.0 0.11
Hemalatha Pillai Shareholding of Promoter and Promoter Group 45813.0 0.1
Vineetha Mohanakumar Pillai Shareholding of Promoter and Promoter Group 32221.0 0.07
Rajitha Gopalakrishnan Shareholding of Promoter and Promoter Group 27500.0 0.06
K R Lakshmi Shareholding of Promoter and Promoter Group 28969.0 0.06
Karuna Ventures Private Limited Shareholding of Promoter and Promoter Group 11105.0 0.02
Triumph Venture Holdings Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Agnus Holdings Pvt Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeswari Amma Shareholding of Promoter and Promoter Group 0.0 0.0
Yalavarthy Usha Rani Shareholding of Promoter and Promoter Group 0.0 0.0

SOLARA ACTIVE PHA SCI LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2021-08-18 3.0 Final 2021-08-20 Equity shares 2020-11-19 4.0 Interim 2020-11-20 Equity shares 2020-07-28 2.0 Final 2020-07-30 Equity shares 2019-08-06 5.0 Final 2019-08-08 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Solara Share Result Highlights

Key Metric

Value

Solara Share Price

₹757.75

Revenue (Qtr Sep 2024)

₹346.95 Cr

Net Profit (Qtr Sep 2024)

₹8.02 Cr

Net Profit Margin

2.31%

Earnings Per Share (EPS)

₹2.11

EBITDA

₹61.64 Cr

Operating Expense

₹339.25 Cr

Key Highlights:

  • Solara share price increased to ₹757.75, gaining ₹16.20 (2.18%) in the latest trading session.

  • The company posted revenue of ₹346.95 Cr for the quarter ending September 2024.

  • Net profit reached ₹8.02 Cr, with a net profit margin of 2.31%.

  • Earnings Per Share (EPS) stood at ₹2.11, indicating solid financial performance.

  • The company’s EBITDA was ₹61.64 Cr, reflecting strong operational profitability.

Solara Share Annual Reports

Report Date

Details

Most Recent Report

September 2024

Revenue for the Year

₹1,350 Cr (Estimated)

Net Profit for the Year

₹30.00 Cr (Estimated)

EPS (Year)

₹8.50

ROE

0.00%

Key Highlights:

  • Solara’s annual report for 2024 estimates revenue of ₹1,350 Cr and net profit of ₹30.00 Cr.

  • The EPS for the year is estimated at ₹8.50, reflecting good profitability.

  • Despite the positive figures, the ROE stands at 0.00%, indicating room for improvement in generating returns for shareholders.

Solara Share Dividend

Year

Dividend

Latest Dividend (2021)

₹3 per share (Final)

Previous Dividend (2020)

₹4 per share (Interim)

Key Highlights:

  • The Solara share price has seen dividend payouts, with the most recent dividend being ₹3 per share in August 2021.

  • In November 2020, the company declared a dividend of ₹4 per share as an interim distribution.

  • Dividend yield for the company stands at 0.00% in the most recent period, reflecting the absence of dividends in recent years.

About SOLARA ACTIVE PHA SCI LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SOLARA ACTIVE PHA SCI LTD

Learn More About Stocks

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Additional FAQs

1. Who is the CEO of Solara Active Pharma Sciences Ltd?

The CEO of Solara Active Pharma Sciences Ltd is Poorvank Purohit, who also serves as the Managing Director of the company.

 

2. When was Solara Active Pharma Sciences Ltd established?

Solara Active Pharma Sciences Ltd was incorporated on February 23, 2017. The company was formed from the demerger of the Active Pharmaceutical Ingredients (API) business from Strides Shasun Ltd.

 

3. What factors influence the Solara Share Price?

The Solara share price is influenced by factors such as financial performance, market conditions, regulatory approvals, and the global demand for active pharmaceutical ingredients. Changes in debt levels, profit margins, and strategic moves like the sale of its stake in Sequent Penems also impact its share price.

 

4. Is Solara Active Pharma Sciences Ltd debt-free?

No, Solara Active Pharma Sciences Ltd is not debt-free. As of March 2024, the company reported borrowings of Rs. 1,012 crores. However, it has been actively working to reduce its working capital requirements over time.

 

5. What is the CAGR of Solara Share?

The Compound Annual Growth Rate (CAGR) of Solara’s stock price over the past five years stands at 13%. However, the three-year CAGR is negative at -7%, reflecting a decline in the stock’s value during that period.

 

6. How has the Solara Share Price performed over the past year?

Over the past year, Solara’s share price has seen a significant increase, rising by 143%, demonstrating a positive market response despite challenges in revenue and profitability.

Frequently Asked Questions

What is the Share Price of Solara Active Pharma Sciences Ltd?

Answer Field

The share price of Solara Active Pharma Sciences Ltd for NSE is ₹ 813.65 and for BSE is ₹ 812.05.

What is the Market Cap of Solara Active Pharma Sciences Ltd?

Answer Field

The market cap of Solara Active Pharma Sciences Ltd for NSE is ₹ 29,28.83 Cr. and for BSE is ₹ 29,23.07 Cr. as of now.

What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?

Answer Field

The 52 Week High and Low of Solara Active Pharma Sciences Ltd for NSE is ₹ 882.80 and ₹ 292.62 and for BSE is ₹ 885.95 and ₹ 292.16.

How to Buy Solara Active Pharma Sciences Ltd share?

Answer Field

You can trade in Solara Active Pharma Sciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Solara Active Pharma Sciences Ltd?

Answer Field

The 1 year returns on the stock has been 168.90%.

What is the Current Share Price of Solara Active Pharma Sciences Ltd?

Answer Field

Solara Active Pharma Sciences Ltd share price is for NSE ₹ 813.65 & for BSE ₹ 812.05 as on Dec 04 2024 03:30 PM.

What is the Market Cap of Solara Active Pharma Sciences Ltd Share?

Answer Field

The market cap of Solara Active Pharma Sciences Ltd for NSE ₹ 29,28.83 & for BSE ₹ 29,23.07 as on Dec 04 2024 03:30 PM.

What is the P/E Ratio of Solara Active Pharma Sciences Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM the price-to-earnings (PE) ratio for Solara Active Pharma Sciences Ltd share is -5.58.

What is the PB ratio of Solara Active Pharma Sciences Ltd Share?

Answer Field

As on Dec 04 2024 03:30 PM, the price-to-book (PB) ratio for Solara Active Pharma Sciences Ltd share is 301.38.

How to Buy Solara Active Pharma Sciences Ltd Share?

Answer Field

You can trade in Solara Active Pharma Sciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Solara Active Pharma Sciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Solara Active Pharma Sciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Solara Active Pharma Sciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader